Copying and distributing are prohibited without permission of the publisher.

Watermark

HutchMed launches $602m secondary listing in Hong Kong

Biotech_PA_575x375_21July.jpg
By Jonathan Breen
18 Jun 2021

Biopharmaceutical company HutchMed (China) kicked off the roadshow for its HK$4.68bn ($602.7m) Hong Kong IPO on Friday, placing more than half of the shares in its third listing with cornerstone investors.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Jonathan Breen
18 Jun 2021